0

Schedule for Master Class On Demand Learning

Session 1 - Malignant and Non-Malignant Hematology

Moderator: Jean M. Connors MD

  • Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

    Ann S. LaCasce MD, MMSC
  • Myeloid Malignancies: Molecular Markets and Targeted Therapies

    Daniel J. DeAngelo, MD, PhD
  • Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

    Ayalew Tefferi, MD
  • Multiple Myeloma: Current Evidence-Based Management

    Kenneth C. Anderson, MD
  • Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

    Matthew S. Davids MD, MMSC
  • Current and Future Treatment Strategies for Cancer Associated Thrombosis

    Jean M. Connors MD
  • Reducing the Sickle Cell Disease Burden with Novel Treatment Targets

    Alexis A. Thompson MD, MPH
  • Panel Discussion

    All Faculty

Session 2 – Women’s Cancers and Supportive Care

Moderator: Harold J. Burstein MD, PhD

Supportive Care

  • Sexual Health in Cancer Survivors

    Sharon L. Bober, PhD
  • Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

    Janet L. Abrahm, MD
  • Supportive Care Questions and Answers

Breast Cancers

  • HER2-Positive Breast Cancer and Triple-Negative Breast Cancer: An Evolving Treatment Landscape

    Nancy U. Lin MD
  • Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

    Harold J. Burstein MD, PhD

Gynecologic Cancers

  • Molecular Advances and Emerging Treatment Strategies In Ovarian Cancer

    Ursula A. Matulonis, MD
  • Molecular Advances and Emerging Treatment Strategies In Endometrial Cancer

    Joyce F. Liu, MD, MPH
  • Panel Discussion

    All Faculty

Session 3 – Gastrointestinal Cancers and Sarcoma

Moderator: Robert J. Mayer MD

Gastrointestinal Cancers

  • Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment

    Robert J. Mayer MD
  • Novel Treatments for Neuroendocrine Tumors: Using Patient and Tumor Characteristics to Guide Treatments

    Jennifer A. Chan, MD, MPH
  • Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers

    Peter C. Enzinger, MD
  • Hepatobiliary Cancer: Predictive Biomarkers, Novel Agents, and Patient Monitoring

    Thomas A. Abrams, MD
  • Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy

    Matthew B. Yurgelun, MD
  • Panel Discussion

    All Faculty

Sarcoma

  • Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma

    George D. Demetri, MD
  • Sarcoma Questions and Answers

Session 4 – Head, Neck and Lung Cancers and Melanoma

Moderator: Bruce E. Johnson MD

Head, Neck and Lung Cancers

  • Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers

    Robert I. Haddad, MD
  • NSCLC and SCLC: Molecular Testing and Emerging Treatment Options

    Bruce E. Johnson MD

Melanoma Cancer

  • Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma

    F. Stephen Hodi, MD
  • Panel Discussion

    All Faculty

Session 5 – Genitourinary Cancers

Moderator: Bruce E. Johnson MD

  • Prostate Cancer: An Evolving Treatment Landscape

    Mary Ellen Taplin, MD
  • Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice

    Robert Dreicer, MD
  • Panel Discussion

    All Faculty
  • Closing Remarks